Biomea Fusion, Inc. ('Biomea” or 'Biomea Fusion” or 'the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that three icovamenib abstracts have been selected for ...
Ahead of the election, the Southern California News Group compiled a list of questions to pose to the candidates vying to represent you.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results